- Home
- FSEA vs ELEV Comparison
FSEA vs ELEV Comparison
Compare FSEA & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ELEV
- Stock Information
- Founded
- FSEA 1890
- ELEV 2019
- Country
- FSEA United States
- ELEV United States
- Employees
- FSEA N/A
- ELEV N/A
- Industry
- FSEA Savings Institutions
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- ELEV Health Care
- Exchange
- FSEA Nasdaq
- ELEV Nasdaq
- Market Cap
- FSEA 43.6M
- ELEV 37.6M
- IPO Year
- FSEA N/A
- ELEV 2021
- Fundamental
- Price
- FSEA $10.17
- ELEV $0.64
- Analyst Decision
- FSEA
- ELEV Strong Buy
- Analyst Count
- FSEA 0
- ELEV 5
- Target Price
- FSEA N/A
- ELEV $7.20
- AVG Volume (30 Days)
- FSEA 10.8K
- ELEV 716.1K
- Earning Date
- FSEA 11-08-2024
- ELEV 11-06-2024
- Dividend Yield
- FSEA N/A
- ELEV N/A
- EPS Growth
- FSEA N/A
- ELEV N/A
- EPS
- FSEA N/A
- ELEV N/A
- Revenue
- FSEA $11,390,000.00
- ELEV N/A
- Revenue This Year
- FSEA N/A
- ELEV N/A
- Revenue Next Year
- FSEA N/A
- ELEV N/A
- P/E Ratio
- FSEA N/A
- ELEV N/A
- Revenue Growth
- FSEA N/A
- ELEV N/A
- 52 Week Low
- FSEA $7.25
- ELEV $0.44
- 52 Week High
- FSEA $10.38
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- FSEA 81.07
- ELEV 57.75
- Support Level
- FSEA $9.25
- ELEV $0.61
- Resistance Level
- FSEA $10.38
- ELEV $0.70
- Average True Range (ATR)
- FSEA 0.25
- ELEV 0.07
- MACD
- FSEA 0.11
- ELEV 0.00
- Stochastic Oscillator
- FSEA 87.02
- ELEV 50.69
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.